Business
Emergent Biosolutions shares plunged after the Covid vaccine maker and federal government “mutually agreed” to cancel contract.
Hi, what are you looking for?
Emergent Biosolutions shares plunged after the Covid vaccine maker and federal government “mutually agreed” to cancel contract.
The vaccine doses have been held in Quarantine since they arrived in April due to a quality control problem.
U.S. regulators are only allowing the release of 10 million doses of Johnson & Johnson's COVID-19 vaccine from a troubled Baltimore factory.
Officials with the Trump administration’s vaccine program, Operation Warp Speed, and the Department of Health and Human Services were sent a report in June...
J&J said it was “assuming full responsibility” of the Emergent BioSolutions facility in Baltimore, reiterating that it will deliver 100 million doses to the...
Baltimore, Maryland-based Emergent BioSolutions was hired to manufacture the active ingredient, or drug substance, of the vaccine at its plant. Workers at the facility...